Sindh High Court (SHC) ordered the federal government on Thursday to set the price of Panadol in four weeks.
The decision was made during the hearing of a petition for contempt of court that the drug’s manufacturer had submitted. It had approached the SHC over the government’s non-compliance of the court’s earlier orders about increasing Panadol’s price.
The representatives of the Drug Regulatory Authority of Pakistan (DRAP) informed the court during the hearings that approval from the federal government was required in order to increase the cost of medications.
The Sindh High Court then ordered the federal government to determine the price of the medication at the following cabinet meeting and provide a report to the court on its findings.
The center’s attorney acknowledged that the topic of the Panadol price was not discussed at the last cabinet meeting.
The pharmaceutical business claimed in its appeal that it purchases the medicine’s raw ingredients in dollars and added that the price of the medication had dramatically increased as a result of the rupee’s persistent depreciation against the dollar in recent weeks.
According to the petitioner, the government was hesitant to raise the cost of the medication.